Highlighting Strategic Progress in Fiscal Year 2026 at the J.P. Morgan Healthcare ConferenceCardinal Health CEO showcases strategic growth, financial milestones,...
Morgan
EMERYVILLE, Calif., Jan. 6, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing...
